Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
315,976,000
-
Total 13F shares
-
97,469,656
-
Share change
-
+97,464,899
-
Total reported value
-
$1,599,487,071
-
Price per share
-
$16.41
-
Number of holders
-
163
-
Value change
-
+$1,599,409,043
-
Number of buys
-
162
Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2018
As of 30 Jun 2018,
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by
163 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,469,656 shares.
The largest 10 holders included
Fosun International Ltd, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., TPG Group Holdings (SBS) Advisors, Inc., AMERIPRISE FINANCIAL INC, MAVERICK CAPITAL LTD, TCW GROUP INC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
163
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.